Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1267-2023Class II

Attune Posterior (PS) Fixed Bearing (FB) Tibial Insert SZ5 7MM, Part Number 151640507

Depuy Orthopaedics Inc. / initiated 2023-02-15 / Open, Classified / root cause: labeling and UDI

DePuy Orthopaedics, Inc. began a recall of Attune Posterior (PS) Fixed Bearing (FB) Tibial Insert SZ5 7MM, Part Number 151640507 on . FDA classified it as Class II and gives the reason as "The subject product lots are being recalled because they received a higher than specified irradiation dose. This exceeds the validated range for exposure to gamma radiation of these devices and may result in changes to...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1267-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Depuy Orthopaedics Inc.
Product
Attune Posterior (PS) Fixed Bearing (FB) Tibial Insert SZ5 7MM, Part Number 151640507
Product code
OIY Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer + Additive/Metal/Polymer + Additive
Reason for recall
The subject product lots are being recalled because they received a higher than specified irradiation dose. This exceeds the validated range for exposure to gamma radiation of these devices and may result in changes to the implant material properties.
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
An URGENT MEDICAL DEVICE RECALL (REMOVAL) notification letter dated 2/14/23 was delivered to customers. Please Take the Following Steps: 1. Examine your inventory immediately to determine if you have the subject products and quarantine the subject products. DO NOT USE THE SUBJECT PRODUCTS. 2. Contact your DePuy Synthes Sales Consultant to coordinate the return/credits of the subject products. 3. Review, complete, sign, and return the attached Business Response Form (See page 3 of this communication) to [email protected] within three (3) business days of receipt of this notification. Please include FA 2220700 Attune Inserts in the e-mail subject line. IMPORTANT: Please complete the attached Business Response Form even if you do not have any units of the subject product on hand. 4. Forward this notice to anyone in your facility that needs to be informed (i.e., those who manage, transport, store, stock, or use the subject products). 5. If any of the subject product has been forwarded to another facility, contact that facility, and provide them with a copy of this notice. 6. Post a copy of this notice in a visible area for awareness and keep a copy for your records. 7. As with any medical device, adverse reactions or quality problems experienced with the use of this product should be reported to the FDA's MedWatch Adverse Event Reporting program: " Online: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reporting-serious-problems-fda Health care providers who have treated patients using the products subject to this removal should continue to follow those patients pursuant to the health care provider s standard of care and may consider more frequent follow-up depending on the activity level and needs of an individual patient. For questions, or to consult with an in-house DePuy Synthes physician on this issue, please submit a Medical Information Request via our website: https://www.jnjmedicaldevices.com/mi
Quantity in commerce
12 units
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Poland, Germany, India, Australia, & New Zealand
Product codes and lots
GTIN: 10603295049944; Lot: JN6613

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1267-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1263-2023Class IIOngoingVoluntary: Firm initiated
Z-1264-2023Class IIOngoingVoluntary: Firm initiated
Z-1265-2023Class IIOngoingVoluntary: Firm initiated
Z-1266-2023Class IIOngoingVoluntary: Firm initiated
Z-1267-2023Class IIOngoingVoluntary: Firm initiated